Annals of Oncology

in this issue

In this issue
Ann Oncol 2008 19: 827; doi:10.1093/annonc/mdn184 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials

R. Labianca, M. Garassino, and V. Torri

Predicting response of molecular targeted therapies: a still possible challenge?
Annals of Oncology Advance Access published on February 21, 2008
Ann Oncol 2008 19: 829-830; doi:10.1093/annonc/mdn016 [Extract] [Full Text] [PDF] [Request Permissions]  

R. Ali and V. Raina

Developing innovative models for North–South cooperation in clinical research—experience from the INDOX Cancer Research Network
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 831-833; doi:10.1093/annonc/mdn034 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews

Get checked abstract A. J. M. Ferreri, R. Dolcetti, M.-Q. Du, C. Doglioni, A. Giordano Resti, L. S. Politi, C. De Conciliis, J. Radford, F. Bertoni, E. Zucca, F. Cavalli, and M. Ponzoni

Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
Annals of Oncology Advance Access published on November 6, 2007
Ann Oncol 2008 19: 835-846; doi:10.1093/annonc/mdm513 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Ganeshan, S. Upponi, Lye-quen Hon, D. Warakaulle, and R. Uberoi

Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology
Annals of Oncology Advance Access published on November 20, 2007
Ann Oncol 2008 19: 847-851; doi:10.1093/annonc/mdm528 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles

breast cancer

Get checked abstract G. Fountzilas, U. Dafni, H. Gogas, H. Linardou, H. P. Kalofonos, E. Briasoulis, D. Pectasides, E. Samantas, D. Bafaloukos, G. P. Stathopoulos, M. Karina, C. Papadimitriou, D. Skarlos, N. Pisanidis, P. Papakostas, C. Markopoulos, E. Tzorakoeleftherakis, K. Dimitrakakis, P. Makrantonakis, N. Xiros, A. Polichronis, I. Varthalitis, C. Karanikiotis, and A. M. Dimopoulos

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00
Annals of Oncology Advance Access published on November 27, 2007
Ann Oncol 2008 19: 853-860; doi:10.1093/annonc/mdm539 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract O. Gluz, U. A. Nitz, N. Harbeck, E. Ting, R. Kates, A. Herr, W. Lindemann, C. Jackisch, W. E. Berdel, H. Kirchner, B. Metzner, F. Werner, G. Schütt, M. Frick, C. Poremba, R. Diallo-Danebrock, and S. Mohrmann On behalf of the West German Study Group

Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
Annals of Oncology Advance Access published on January 3, 2008
Ann Oncol 2008 19: 861-870; doi:10.1093/annonc/mdm551 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract P. Schmid, D. Kühnhardt, P. Kiewe, S. Lehenbauer-Dehm, W. Schippinger, R. Greil, W. Lange, J. Preiss, N. Niederle, P. Brossart, W. Freier, S. Kümmel, H. Van de Velde, A. Regierer, and K. Possinger

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
Annals of Oncology Advance Access published on January 21, 2008
Ann Oncol 2008 19: 871-876; doi:10.1093/annonc/mdm569 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract J. N. Ingle, D. Tu, J. L. Pater, H. B. Muss, S. Martino, N. J. Robert, M. J. Piccart, M. Castiglione, L. E. Shepherd, K. I. Pritchard, R. B. Livingston, N. E. Davidson, L. Norton, E. A. Perez, J. S. Abrams, D. A. Cameron, M. J. Palmer, and P. E. Goss

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
Annals of Oncology Advance Access published on March 10, 2008
Ann Oncol 2008 19: 877-882; doi:10.1093/annonc/mdm566 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract V. Ludovini, S. Gori, M. Colozza, L. Pistola, E. Rulli, I. Floriani, E. Pacifico, F. R. Tofanetti, A. Sidoni, C. Basurto, A. Rulli, and L. Crinò

Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival
Annals of Oncology Advance Access published on January 10, 2008
Ann Oncol 2008 19: 883-890; doi:10.1093/annonc/mdm585 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract F. Nolé, E. Munzone, L. Zorzino, I. Minchella, M. Salvatici, E. Botteri, M. Medici, E. Verri, L. Adamoli, N. Rotmensz, A. Goldhirsch, and M. T. Sandri

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
Annals of Oncology Advance Access published on December 4, 2007
Ann Oncol 2008 19: 891-897; doi:10.1093/annonc/mdm558 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors

Get checked abstract S. V. Barrett, J. Paul, A. Hay, P. A. Vasey, S. B. Kaye, and R. M. Glasspool On behalf of the Scottish Gynaecological Cancer Trials Group

Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 898-902; doi:10.1093/annonc/mdm606 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors

Get checked abstract R. Bettini, L. Boninsegna, W. Mantovani, P. Capelli, C. Bassi, P. Pederzoli, G. F. Delle Fave, F. Panzuto, A. Scarpa, and M. Falconi

Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours
Annals of Oncology Advance Access published on January 21, 2008
Ann Oncol 2008 19: 903-908; doi:10.1093/annonc/mdm552 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract B. Glimelius, H. Sørbye, L. Balteskard, P. Byström, P. Pfeiffer, K. Tveit, R. Heikkilä, N. Keldsen, M. Albertsson, H. Starkhammar, H. Garmo, and Å. Berglund

A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
Annals of Oncology Advance Access published on January 21, 2008
Ann Oncol 2008 19: 909-914; doi:10.1093/annonc/mdm588 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract R. Soong, N. Shah, M. Salto-Tellez, B. C. Tai, R. A. Soo, H. C. Han, S. S. Ng, W. L. Tan, N. Zeps, D. Joseph, R. B. Diasio, and B. Iacopetta

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
Annals of Oncology Advance Access published on February 1, 2008
Ann Oncol 2008 19: 915-919; doi:10.1093/annonc/mdm599 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C.-H. Köhne, J. De Greve, J. T. Hartmann, I. Lang, P. Vergauwe, K. Becker, D. Braumann, E. Joosens, L. Müller, J. Janssens, C. Bokemeyer, P. Reimer, H. Link, E. Späth-Schwalbe, H.-J. Wilke, H. Bleiberg, J. Van Den Brande, M. Debois, U. Bethe, and E. Van Cutsem

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
Annals of Oncology Advance Access published on December 6, 2007
Ann Oncol 2008 19: 920-926; doi:10.1093/annonc/mdm544 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract J.-J. Mourad, G. des Guetz, H. Debbabi, and B. I. Levy

Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
Annals of Oncology Advance Access published on December 4, 2007
Ann Oncol 2008 19: 927-934; doi:10.1093/annonc/mdm550 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract J. Sastre, M. L. Maestro, J. Puente, S. Veganzones, R. Alfonso, S. Rafael, J. A. García-Saenz, M. Vidaurreta, M. Martín, M. Arroyo, M. T. Sanz-Casla, and E. Díaz-Rubio

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
Annals of Oncology Advance Access published on January 22, 2008
Ann Oncol 2008 19: 935-938; doi:10.1093/annonc/mdm583 [Abstract] [Full Text] [PDF] [Request Permissions]  

lung cancer

Get checked abstract M. H. Cullen, P. Zatloukal, S. Sörenson, S. Novello, J. R. Fischer, A. A. Joy, M. Zereu, P. Peterson, C. M. Visseren-Grul, and N. Iscoe

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
Annals of Oncology Advance Access published on February 17, 2008
Ann Oncol 2008 19: 939-945; doi:10.1093/annonc/mdm592 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors

Get checked abstract J. E. Rosenberg, S. Halabi, B. L. Sanford, A. L. Himelstein, J. N. Atkins, R. J. Hohl, F. Millard, D. F. Bajorin, E. J. Small, and For the Cancer and Leukemia Group B

Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 946-950; doi:10.1093/annonc/mdm600 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies

Get checked abstract A. Re, S. Ferrari, P. Frata, C. Pizzocaro, C. Crippa, A. Tucci, F. Facchetti, L. Grazioli, S.M. Magrini, and G. Rossi

Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study
Annals of Oncology Advance Access published on January 21, 2008
Ann Oncol 2008 19: 951-957; doi:10.1093/annonc/mdm596 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S. Mercadal, J. Briones, B. Xicoy, C. Pedro, L. Escoda, C. Estany, M. Camós, L. Colomo, Í. Espinosa, S. Martínez, J.M. Ribera, R. Martino, G. Gutiérrez-García, E. Montserrat, A. López-Guillermo, and On behalf of the Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
Annals of Oncology Advance Access published on February 25, 2008
Ann Oncol 2008 19: 958-963; doi:10.1093/annonc/mdn022 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract M. Crump, B. Coiffier, E. D. Jacobsen, L. Sun, J. L. Ricker, H. Xie, S. R. Frankel, S. S. Randolph, and B. D. Cheson

Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma
Annals of Oncology Advance Access published on February 21, 2008
Ann Oncol 2008 19: 964-969; doi:10.1093/annonc/mdn031 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract F. Wimazal, W. R. Sperr, M. Kundi, A. Vales, C. Fonatsch, R. Thalhammer-Scherrer, I. Schwarzinger, and P. Valent

Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 970-976; doi:10.1093/annonc/mdm595 [Abstract] [Full Text] [PDF] [Request Permissions]  

head and neck cancer

Get checked abstract B. A. Burtness, J. Manola, R. Axelrod, A. Argiris, and A. A. Forastiere

A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study
Annals of Oncology Advance Access published on February 21, 2008
Ann Oncol 2008 19: 977-983; doi:10.1093/annonc/mdm591 [Abstract] [Full Text] [PDF] [Request Permissions]  

supportive Care

Get checked abstract O. Penack, P. Rempf, B. Graf, I. W. Blau, and E. Thiel

Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management
Annals of Oncology Advance Access published on January 27, 2008
Ann Oncol 2008 19: 984-989; doi:10.1093/annonc/mdm571 [Abstract] [Full Text] [PDF] [Request Permissions]  

phase I and pharmacokinetics

Get checked abstract A. Greystoke, J. Cummings, T. Ward, K. Simpson, A. Renehan, F. Butt, D. Moore, J. Gietema, F. Blackhall, M. Ranson, A. Hughes, and C. Dive

Optimisation of circulating biomarkers of cell death for routine clinical use
Annals of Oncology Advance Access published on February 27, 2008
Ann Oncol 2008 19: 990-995; doi:10.1093/annonc/mdn014 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology

Get checked abstract G. D. Batty, M. Kivimaki, L. Gray, G. Davey Smith, M. G. Marmot, and M. J. Shipley

Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study
Annals of Oncology Advance Access published on January 22, 2008
Ann Oncol 2008 19: 996-1002; doi:10.1093/annonc/mdm578 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Pelucchi, C. Galeone, M. Montella, J. Polesel, A. Crispo, R. Talamini, E. Negri, V. Ramazzotti, M. Grimaldi, S. Franceschi, and C. La Vecchia

Alcohol consumption and renal cell cancer risk in two Italian case–control studies
Annals of Oncology Advance Access published on January 10, 2008
Ann Oncol 2008 19: 1003-1008; doi:10.1093/annonc/mdm590 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Héry, J. Ferlay, M. Boniol, and P. Autier

Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations
Annals of Oncology Advance Access published on February 21, 2008
Ann Oncol 2008 19: 1009-1018; doi:10.1093/annonc/mdm593 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor

H. Ishiguro, T. Kitano, H. Yoshibayashi, M. Toi, T. Ueno, H. Yasuda, K. Yanagihara, C. L. Garbo, and M. Fukushima

Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 1019; doi:10.1093/annonc/mdn051 [Extract] [Full Text] [PDF] [Request Permissions]  

P. Piedbois, D. Serin, F. Priou, P. Laplaige, J.-F. Berdah, and J. Grenier

Reply to Letter to the editor, by Ishiguro et al. (Ann Oncol)
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 1019-1020; doi:10.1093/annonc/mdn053 [Extract] [Full Text] [PDF] [Request Permissions]  

M. V. Karamouzis, P. A. Konstantinopoulos, and A. G. Papavassiliou

ErbB/HER receptor family in breast cancer—the more we search the more we learn
Annals of Oncology Advance Access published on March 19, 2008
Ann Oncol 2008 19: 1020-1021; doi:10.1093/annonc/mdn061 [Extract] [Full Text] [PDF] [Request Permissions]  

G. Apolone, O. Corli, M. T. Greco, V. Zagonel, and on behalf of the CPOR SG Investigators

Factors influencing the decision to take or reject opioids for cancer pain: are we on target?
Annals of Oncology Advance Access published on March 28, 2008
Ann Oncol 2008 19: 1021-1022; doi:10.1093/annonc/mdn069 [Extract] [Full Text] [PDF] [Request Permissions]  

H.-M. Baek, J.-H. Chen, O. Nalcioglu, and M.-Y. Su

Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy
Annals of Oncology Advance Access published on March 27, 2008
Ann Oncol 2008 19: 1022-1024; doi:10.1093/annonc/mdn121 [Extract] [Full Text] [PDF] [Request Permissions]  

J. H. Chen, O. Nalcioglu, and M. Y. Su

MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
Annals of Oncology Advance Access published on March 28, 2008
Ann Oncol 2008 19: 1024-1026; doi:10.1093/annonc/mdn120 [Extract] [Full Text] [PDF] [Request Permissions]  

G. Jaeger, F. Bauer, R. Brezinschek, C. Beham-Schmid, C. Mannhalter, and P. Neumeister

Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine
Annals of Oncology Advance Access published on March 28, 2008
Ann Oncol 2008 19: 1025-1026; doi:10.1093/annonc/mdn119 [Extract] [Full Text] [PDF] [Request Permissions]  

corrigendum

Volume 18, Supplement 2, ESMO Clinical Recommendations
Annals of Oncology Advance Access published on April 11, 2008
Ann Oncol 2008 19: 1027-1029; doi:10.1093/annonc/mdn158 [Extract] [Full Text] [PDF] [Request Permissions]  

Burden of cervical cancer in Europe: estimates for 2004
Ann Oncol 2008 19: 1030; doi:10.1093/annonc/mdn159 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.